In 2016, a study published in the journal Diabetes Care offered new hope to men with type 2 diabetes. It found that six months of testosterone therapy significantly reduced insulin and glucose levels in men with type 2 diabetes who were also testosterone deficient. The therapy also reduced the men’s body fat by an average of nearly seven pounds, increased their muscle mass, improved their sexual function, and lowered their C-reactive protein levels, a blood marker of inflammation that has been linked to cardiovascular disease risk.
Daily Archives